| Cole Davis, MD | |
|
10901 E 48th St, Tulsa, OK 74146-5830 | |
| (918) 749-8765 | |
| (918) 392-2155 |
| Full Name | Cole Davis |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 21 Years |
| Location | 10901 E 48th St, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205975224 | NPI | - | NPPES |
| 200289020A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 27679 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oklahoma Surgical Hospital, Llc | Tulsa, OK | Hospital |
| Mercy Hospital Joplin | Joplin, MO | Hospital |
| St John Medical Center, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital Muskogee | Muskogee, OK | Hospital |
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Urologic Specialists Of Oklahoma Inc | 3779470091 | 34 |
| Mercy Clinic Joplin Llc | 0547300196 | 247 |
| Urologic Specialists Of Oklahoma Inc | 3779470091 | 34 |
News Archive
WellPoint, Inc. today announced that fourth quarter 2009 net income was $2.7 billion, or $5.95 per share. The results included net after-tax income of approximately $2.2 billion, or $4.79 per share, resulting from a gain on the sale of the NextRx pharmacy benefit management subsidiaries ("NextRx"), partially offset by costs for restructuring activities and intangible asset impairments.
Radiometer is proud to announce that it is sponsoring this year's World Sepsis Day on the 13th September, continuing its commitment to the fight against this life-threatening medical condition.
Jia Shen, a student at The University of Texas Graduate School of Biomedical Sciences at Houston, is a recipient of a 2013 Jess Hay Chancellor's Graduate Student Research Fellowship. This award is given to two students per year across the entire University of Texas System, which is comprised of nine universities and six health institutions.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
› Verified 4 days ago
| Entity Name | Urologic Specialists Of Oklahoma Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174546162 PECOS PAC ID: 3779470091 Enrollment ID: O20140725001707 |
News Archive
WellPoint, Inc. today announced that fourth quarter 2009 net income was $2.7 billion, or $5.95 per share. The results included net after-tax income of approximately $2.2 billion, or $4.79 per share, resulting from a gain on the sale of the NextRx pharmacy benefit management subsidiaries ("NextRx"), partially offset by costs for restructuring activities and intangible asset impairments.
Radiometer is proud to announce that it is sponsoring this year's World Sepsis Day on the 13th September, continuing its commitment to the fight against this life-threatening medical condition.
Jia Shen, a student at The University of Texas Graduate School of Biomedical Sciences at Houston, is a recipient of a 2013 Jess Hay Chancellor's Graduate Student Research Fellowship. This award is given to two students per year across the entire University of Texas System, which is comprised of nine universities and six health institutions.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cole Davis, MD 10901 E 48th St, Tulsa, OK 74146-5830 Ph: (918) 749-8765 | Cole Davis, MD 10901 E 48th St, Tulsa, OK 74146-5830 Ph: (918) 749-8765 |
News Archive
WellPoint, Inc. today announced that fourth quarter 2009 net income was $2.7 billion, or $5.95 per share. The results included net after-tax income of approximately $2.2 billion, or $4.79 per share, resulting from a gain on the sale of the NextRx pharmacy benefit management subsidiaries ("NextRx"), partially offset by costs for restructuring activities and intangible asset impairments.
Radiometer is proud to announce that it is sponsoring this year's World Sepsis Day on the 13th September, continuing its commitment to the fight against this life-threatening medical condition.
Jia Shen, a student at The University of Texas Graduate School of Biomedical Sciences at Houston, is a recipient of a 2013 Jess Hay Chancellor's Graduate Student Research Fellowship. This award is given to two students per year across the entire University of Texas System, which is comprised of nine universities and six health institutions.
Two female brain tumor patients have become the first people in the south of England to be treated using a faster form of radiotherapy that extends more advanced care to more patients. RapidArc technology from Varian Medical Systems (NYSE: VAR) makes it possible to deliver image-guided IMRT (intensity modulated radiotherapy) two to eight times faster than is possible with conventional IMRT.
Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.
› Verified 4 days ago
Dr. Dae Y Kim, M.D., PH.D Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Suite 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 | |
Dr. Clarence Michael Johnson, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 802 S Jackson Ave, Suite 110, Tulsa, OK 74127 Phone: 918-599-4477 Fax: 918-599-4479 | |
Bruce Carlton Stoesser, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 10901 E 48th St S, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Kevin Joseph Gancarczyk, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Rustin Chanc Walters, M.D. Urology Medicare: Medicare Enrolled Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Jack Steve Miller, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Paul G Hagood, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 |